Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients
Matthew Schuelke, Hamid Bassiri, Edward M. Behrens, Scott Canna, Colleen Croy, Amanda M. DiNofia, Kandace Gollomp, Stephan A. Grupp, Michele P. Lambert, Arathi A Lambrix, Shannon L. Maude, Regina M. Myers, Haley Newman, Whitney Petrosa, Alix E. Seif, Kathleen E. Sullivan, David T. Teachey, Caroline Diorio
Topics & Concepts
Refractory (planetary science)MedicineCytokineCytokine release syndromeInternal medicineBiologyCoronavirus disease 2019 (COVID-19)DiseaseAstrobiologyInfectious disease (medical specialty)Autoimmune and Inflammatory Disorders ResearchImmune Cell Function and InteractionAdolescent and Pediatric Healthcare